Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. TEM
TEM logo

TEM

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

TEM News

Analysis of ARKK ETF's 52-Week Price Fluctuations

5d agoNASDAQ.COM

Tempus AI Shareholder Sell-off Raises Market Concerns

6d agostocktwits

SoundThinking and SELLAS Options Trading Activity

Jun 25 2026NASDAQ.COM

Tempus AI Partners with Angiosarcoma Awareness to Advance Research

Jun 25 2026Newsfilter

Ventripoint Joins Global Congenital Heart Disease Alliance to Enhance Care Access

Jun 16 2026Newsfilter

Tempus AI Receives FDA Clearance for Atrial Fibrillation Prediction Software

Jun 11 2026Newsfilter

ExomeReveal RNA Analysis Enhances Genetic Diagnosis Clarity

Jun 09 2026Newsfilter

Tempus AI Expands Beyond Diagnostics with Healthcare Data Platform

Jun 08 2026Fool

Tempus AI Aims for Profitable Growth Potential Beyond Diagnostics

Jun 08 2026NASDAQ.COM

AstraZeneca CEO Discusses AI's Role in Drug Development

Jun 05 2026CNBC

Tempus AI Launches Digital Pathology Open-Source Consortium

Jun 03 2026Newsfilter

Tempus AI Launches Next-Generation Genetic Test for Oncology

Jun 01 2026Newsfilter

Tempus Launches Next-Gen AI Platform Lens to Accelerate Drug Development

May 31 2026Newsfilter

Tempus Launches PRECISION Challenge to Accelerate Oncology Breakthroughs

May 30 2026Newsfilter

Tempus AI Launches Rapid Clinical Insights Application

May 30 2026Newsfilter

Tempus AI Unveils New AI-Driven Precision Medicine Data

May 29 2026seekingalpha